Verve Therapeutics, Inc. (VERV)
NASDAQ: VERV · Real-Time Price · USD
5.51
+0.12 (2.23%)
At close: Sep 18, 2024, 4:00 PM
5.62
+0.11 (2.00%)
After-hours: Sep 18, 2024, 4:58 PM EDT
Verve Therapeutics Market Cap
Verve Therapeutics has a market cap or net worth of $466.28 million as of September 18, 2024. Its market cap has decreased by -45.60% in one year.
Market Cap
466.28M
Enterprise Value
-37.19M
1-Year Change
-45.60%
Ranking
Category
Stock Price
$5.51
Market Cap Chart
Since the IPO on June 17, 2021, Verve Therapeutics's market cap has decreased from $869.34M to $466.28M, a decrease of -46.36%. That is a compound annual growth rate of -17.42%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Sep 17, 2024 | 456.10M | -48.68% |
| Dec 29, 2023 | 888.70M | -25.44% |
| Dec 30, 2022 | 1.19B | -32.89% |
| Dec 31, 2021 | 1.78B | 104.31% |
View and export this data all the way back to 2021.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Valneva SE | 499.62M |
| Tourmaline Bio | 494.75M |
| Contineum Therapeutics | 493.50M |
| Aura Biosciences | 491.10M |
| Cross Country Healthcare | 489.21M |
| EyePoint Pharmaceuticals | 483.80M |
| ZimVie | 478.10M |
| KalVista Pharmaceuticals | 477.96M |